Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hubbell (HUBB) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Hubbell vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Hubbell trades at $471.77 (market cap $25.25B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Hubbell is far larger — about 2.3× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Hubbell pays the higher dividend (1.19%). Which is the better fit depends on your goals — on Pluang, investors hold Hubbell for 6 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

HUBBRDY
Market Cap
$25.25B$10.78B
Volume
443,3192,724,343
Sector
IndustrialsHealth
52-Week High
$557.85$15.38
52-Week Low
$407.36$11.38
Typical Hold Time
6 Days0 Days
Enterprise Value
$30.41B$10.68B
Dividend Yield
1.19%0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hubbell

Hubbell Incorporated (HUBB) trades at $477.93, up 0.82% with a neutral technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025: $4.73 vs. $4.71 expected, Q1 2026: $3.93 vs. $3.87, Q2 2026: $5.52 vs. $5.39) and robust profitability (net margin 14.49%, ROE 24.34%). Recent news highlights grid modernization opportunities and institutional buying interest from Bank of America and BNY Mellon.

Hubbell presents a favorable outlook with analyst consensus price target of $560.50 (17% upside) and strong institutional support. Key risks include integration challenges from recent acquisitions and dependence on utility spending cycles. The Q3 2026 earnings report on October 27 will be crucial for validating growth trajectory amid electrification demand.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUBB

No sentiment data available yet.

RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Hubbell

Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.

Read more on HUBB →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →